Ep151: Shelley Force Aldred and Nathan Trinklein on Bispecific Antibodies for Cancer
Podcast: The Long Run with Luke TimmermanPublished On: Tue Dec 26 2023
Description: Shelley Force Aldred and Nathan Trinklein, co-founders of Rondo Therapeutics, on the opportunity with bispecific antibodies for cancer.
The note was deleted
The note was saved
Your message was sent